CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells

Journal of Immunology

Volumn 152, Issue 7, 1994, Pages 3361-3369

  Nandi, Dipankar ^a,b   Gross, Jane A ^a,c   Allison, James P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD28; ANTIGENS, CD80; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; IMMUNITY, CELLULAR; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOKINES; MICE; MICE, INBRED C57BL; MICE, SCID; TETRADECANOYLPHORBOL ACETATE;

EID: 0028230410     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Schwartz, R. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71:1065.
2. Linsley, P., E. A. Clark, and J. A. Ledbetter. 1990. The T cells antigen, CD28, mediates adhesion with B cells by interacting with the activation antigen, B7. Proc. Natl. Acad. Sci. USA 87:5031.
3. Freeman, G. J., G. S. Gray, C. D. Gimmi, D. B. Lombard, L.-J. Zhou, M. White, J. D. Fingeroth, J. G. Gribben, and L. M. Nadler. 1991. Structure, expression, and the T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J. Exp. Med. 174:625.
4. Linsley, P. S., W. Brady, L. Grosmaire, A. Aruffo, N. K. Damle, and J. A. Ledbetter. 1991. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and IL-2 mRNA accumulation. J. Exp. Med. 173:721.
5. Gimmi, C. D., G. J. Freeman, J. G. Gribben, K. Sugita, A. S. Freedman, C. Morimoto, and L. M. Nadler. 1991. B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc. Natl. Acad. Sci. USA 88:6575.
6. Jenkins, M., P. S. Taylor, S. D. Norton, and K. B. Urdahl. 1991. CD28 delivers a costimulatory signal involved in antigen specific IL-2 production by human T cells. J. Immunol. 147:2461.
7. Harding, F., J. McArthur, J. A. Gross, D. Raulet, and J. P. Allison. 1992. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356:607.
8. + CTLs in the absence of exogenous help. J. Exp. Med. 177:1791.
9. Azuma, M., M. Cayabyab, D. Buck, J. H. Phillips, and L. L. Lanier. 1992. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J. Exp. Med. 175:353.
10. Azuma, M., M. Cayabyab, J. H. Phillips, and L. L. Lanier. 1993. Requirements for CD28-dependent T cell-mediated cytotoxicity. J. Immunol. 150:2091.
11. Lanier L., and J. H. Phillips. 1992. Natural killer cells. Curr. Opinion Immunol. 4:38.
12. Perussia, B. 1991. Lymphokine-activated killer cells, natural killer cells and cytokines. Curr. Opinion Immunol. 3:49.
13. Yokoyama, W. M., and W. E. Seaman. 1993. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu. Rev. Immunol 11:613.
14. Perussia, B., C. Ramoni, I. Anegon, M. C. Cuturi, J. Faust, and G. Trinchieri. 1987. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines. Nat. Immun. Cell Growth Regul. 6:171.
15. Robertson, M. J., T. J. Manley, C. Donahue, H. Levine, and J. Ritz. 1993. Costimulatory signals are required for optimal proliferation of human natural killer cells. J. Immunol. 150:1705.
16. Tutt, M. M., W. Schuler, W. A. Kuziel, P. W. Tucker, M. Bennett, M. J. Bosma, and V. Kumar. 1987. T cell receptor genes do not rearrange or express functional transcripts in natural killer cells of SCID mice. J. Immunol. 138:2338.
17. Koo, G. C., and J. R. Peppard. 1984. Establishment of monoclonal anti-NK1.1 antibody. Hybridoma 3:301.
18. Kubo, R. T., W. Born, J. W. Kappler, P. Marrack, and M. Pigeon. 1989. Characterization of a monoclonal antibody which detects all murine αβ T cell receptors. J. Immunol: 142:2736.
19. Goodman, T., and L. Lefrancois. 1989. Intraepithelial lymphocytes: Anatomical site, not T cell receptor form, dictates phenotype and function. J. Exp. Med. 170:1569.
20. Ceredig, R., J. W. Lowenthal, M. Naboltz, and H. R. MacDonald. 1985. Expression of interleukin receptors as a differentiation marker on intrathymic stem cells. Nature 314:98.
21. Gross, J. A., E. Callas, and J. P. Allison. 1992. Identification and distribution of the costimulatory receptor CD28 in the mouse. J. Immunol. 149:380.
22. Allison, J. P., W. L. Havran, M. Poenie, J. Kimura, L. Degraffenreid, S. Ajami, G. Duwe, A. Weiss, and R. Tsien. 1987. Expression and function of CD3 on murine thymocytes. In The T Cell Receptor, UCLA Symposia on Molecular and Cellular Biology, New Series. J. Kappler and M. Davis, eds. Alan R. Liss, Inc., New York, p. 33.
23. Ozata, K., and D. H. Sachs. 1981. Monoclonal antibodies to mouse MHC antigens: hybridoma antibodies reacting to antigens of the H-2h haplotype reveal genetic control of isotype expression. J. Immunol. 126:317.
24. Symington, F. W., and J. Sprent. 1981. A monoclonal antibody detecting an Ia specificity mapping in the I-A or 1-E subregion. Immunogenetics 14:53.
25. Dialynas, D. P., Z. S. Quan, K. A. Wall, A. Pierres, J. Quintas, M. R. Loken, M. Pierres, and F. W. Fitch. 1983. Characterization of the murine T cell surface molecule, L3T4, identified by monoclonal antibody GK.1.5: Similarity of L3T4 to the human Leu3T4 molecule. J. Immunol. 131:2445.
26. Sariento, M., A. Glasegrook, and F. W. Fitch. 1980. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt2 antigen block T cell-mediated cytolysis in the absence of complement. J. Immunol. 125:2665.
27. Lanier, L. L., G. A. Gutman, D. E. Lewis, S. T. Griswold, and N. L. Warner. 1982. Monoclonal antibodies against rat immunoglobulin κ chains. Hybridoma 1:125.
28. Djeu, J. Y., J. A. Heinbaugh, H. T. Holden, and R. B. Herberman. 1979. Augmentation of mouse natural killer cell activity by IFN and IFN inducers. J. Immunol. 122:175.
29. Schreiber, R. D., L. J. Hicks, A. Celada, N. A. Buchmeier, and P. W. Gray. 1985. Monoclonal antibodies to murine IFN-γ which differentially modulate macrophage activation and antiviral activity. J. Immunol. 134:1609.
30. Teng, M., B. H. Park, H. Koeppen, K. J. Tracey, B. M. Fendly, and H. Schreiber. 1991. Long term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity. Proc. Natl. Acad. Sci. USA 88:3535.
31. Koo, G. C., J. B. Jacobson, G. Hammerling, and U. Hammerling. 1980. Antigenic profile of murine natural killer cells. J. Immunol. 125:1003.
32. + subset. J. Immunol. 145:1039.
33. Anegon, I., M. C. Cuturi, G. Trinchieri, and B. Perussia. 1988. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. J. Exp. Med. 167:452.
34. 2+ mobilization and phosphoinositide turnover in human natural killer cells. J. Exp. Med. 169:549.
35. Keller, R. 1979. Suppression of natural antitumor defence mechanisms by phorbol esters. Nature 282:729.
36. Benussan, A., B. Tourvielle, L. Chen, J. Dausset, and M. Sasportes. 1985. Phorbol ester induces a differential effect on the effector function of human allospecific cytotoxic T lymphocyte and natural killer clones. Proc. Natl. Acad. Sci. USA 82:6642.
37. Hansen, J. A., P. J. Martin, and R. C. Nowinski. 1980. Monoclonal antibodies identifying a novel T-cell antigen and Ia antigens of human lymphocytes. Immunogenetics 10:247.
38. Nagler, A., L. L. Lanier, S. Cwirla, and J. H. Phillips. 1989. Comparative studies of human FcRIII-positive and negative NK cells. J. Immunol. 143:3183.
39. Van Den Brink, M. R. M., S. S. Boggs, R. B. Heberman, and J. C. Hiserodt. 1990. The generation of natural killer (NK) cells from NK precursor cells in rat long-term bone marrow cultures. J. Exp. Med. 172:303.
40. Robertson, M. J., R. J. Soiffer, S. F. Wolf, T. J. Manley, C. Donahue, D. Young, S. H. Herrmann, and J. Ritz. 1992. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J. Exp. Med. 175:779.
41. Thompson, C. B., T. Lindsten, J. A. Ledbetter, S. L. Kunkel, H. A. Young, S. G. Emerson, J. M. Leiden, and C. H. June. 1989. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc. Natl. Acad. Sci. USA 86:1333.
42. Fraser, J. D., B. A. Irving, G. R. Crabtree, and A. Weiss. 1991. Regulation of interleukin-2 gene enhancer activity by the T-cell accessory molecule CD28. Science 251:313.
43. Lindsten, T., C. H. June, J. A. Ledbetter, G. Stella, and C. B. Thompson. 1989. Regulation of lymphokine messenger RNA stability level by a surface-mediated T cell activation pathway. Science 244:339.
44. Azuma, M., M. Cayabyab, D. Buck, J. H. Phillips, and L. L. Lanier. 1992. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. J. Immunol. 149:1115.
45. Lanier, L., H. Spits, and J. H. Phillips. 1992. The developmental relationship between NK cells and T cells. Immunol. Today 13:392.
46. Karlhoffer, F. M., and W. M. Yokoyama. 1991. Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen: IL-2 activated NK cells possess additional specific stimulation pathways. J. Immunol. 146:3662.
47. Giorda, R., W. A. Rudert, C. Vavassori, W. H. Chambers, J. C. Hiserodt, and M. Trucco. 1990. NKR-P1, a signal transduction molecule on natural killer cells. Science 249:1298.
48. Siliciano, R. F., J. C. Pratt, R. E. Schmidt, J. Ritz, and E. L. Reinherz. 1985. Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein. Nature 317:428.
49. Seaman, W. E., E. C. Niemi, M. R. Stark, R. D. Goldfien, A. S. Pollock, and J. B. Imboden. 1991. Molecular cloning of gp42: a cell surface molecule that is selectively induced on rat natural killer cells by interleukin-2: glycolipid membrane anchoring and capacity for transmembrane anchoring and capacity for transmembrane signalling. J. Exp. Med. 173:251.
50. Welsh, R. M., J. O. Brubaker, M. Vargas-Cortes, and C. L. O'Don-nell 1991. Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency: the stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function. J. Exp. Med. 173:1053.
51. Seaman, W. E., M. Sleisenger, E. Erikson, E. Eriksson, and G. Koo. 1987. Depletion of natural killer cells in mice by monoclonal antibody to NK1.1: reduction in host defense against malignancy without loss of cellular or humoral immunity. J. Immunol. 138:4539.
52. + T cells by B7-transfected melanoma cells. Science 259:368.
53. Chen, L., S. Ashe, W. A. Brady, I. Hellstrom, K. E. Hellstrom, J. A. Ledbetter, P. McGowan, and P. S. Linsley. 1993. Costimulation of antitumor immunity by the B7 counterreceptor or the T lymphocyte molecules CD28 and CTLA4. Cell 71:1093.
54. Bancroft, G. J., K. C. F. Sheehan, R. D. Schreiber, and E. R. Unanue. 1989. Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in SCID mice. J. Immunol. 143:127.